Anti-obesity effects of boussingaulti gracilis miers var. pseudobaselloides bailey via activation of AMP-activated protein kinase in 3T3-L1 cells

Journal of Medicinal Food

Volumn 15, Issue 9, 2012, Pages 811-817

  Kim, Hana ^a   Choung, Se Young ^a  

^a Kyung Hee University   (South Korea)

Author keywords

oxidation; AMP activated protein kinase; anti obesity; antilipogenesis; Boussingaulti gracilis Miers var. pseudobaselloides Bailey

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ANTIOBESITY AGENT; BOUSSINGAULTI GRACILIS EXTRACT; CCAAT ENHANCER BINDING PROTEIN ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; PROTEIN KINASE; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANTIOBESITY ACTIVITY; ARTICLE; AUSTROBAILEYALES; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; GENE EXPRESSION; LIPID STORAGE; PRIORITY JOURNAL; PROADIPOCYTE;

3T3-L1 CELLS; ACETYL-COA CARBOXYLASE; ADIPOCYTES; ADIPOGENESIS; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-OBESITY AGENTS; DIETARY SUPPLEMENTS; EMBRYOPHYTA; ENZYME ACTIVATORS; GENE EXPRESSION REGULATION; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; MICE; PHOSPHORYLATION; PLANT EXTRACTS; PLANT LEAVES; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION;

RATTUS;

EID: 84865679644     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2011.2126     Document Type: Article

References (29)

1. WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
2. Unger RH: Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003;14:398-403. (Pubitemid 37392211)
3. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119. (Pubitemid 40629025)
4. Luque CA, Rey JA: Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Ann Pharmacother 1999; 33:968-978. (Pubitemid 29420996)
5. Leite CE, Mocelin CA, Petersen GO, Leal MB, Thiesen FV: Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol Rep 2009;61:217-224.
6. Heck AM, Yanovski JA, Calis KA: Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 2000; 20:270-279. (Pubitemid 30140745)
7. Lagouge M, Argmann C, Grhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J: Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1a. Cell 2006;127:1-14.
8. Shang J, Chen LL, Xiao FX: [Resveratrol improves high-fat induced nonalcoholic fatty liver in rats]. Zhonghua Gan Zang Bing Za Zhi 2008;16:616-619.
9. Shang J, Chen LL, Xiao FX, Sun H, Ding HC, Xiao H: Resveratrol improves non-alcoholic fatty liver disease by activating AMPactivated protein kinase. Acta Pharmacol Sin 2008;29:698-706. (Pubitemid 351799479)
10. Ha DT, Trung TN, Phuong TT, Yim N, Chen QC, Bae K: The selected flavonol glycoside derived from Sophorae Flos improves glucose uptake and inhibits adipocyte differentiation via activation AMPK in 3T3-L1 cells. Bioorg Med Chem Lett 2010;20: 6076-6081.
11. Rayalam S, Della-Fera MA, Baile CA: Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem 2008; 19:717-726.
12. Kan WS: Pharmaceutical Botany. National Research Institute of Chinese Medicine, Taipei, 1986.
13. Lin WC, Wu SC, Kuo SC: Inhibitory effects of ethanolic extracts of Boussingaultia gracilis on the spasmongen-induced contractions of the rat isolated gastric fundus. J Ethnopharmacol 1997;56:89-93.
14. Lin WC, Wu SC, Kuo SC: Prevention of ethanol-induced gastric lesions in rats by ethanolic extracts of Boussingaultia gracilis. Chin Pharm J 1996;48:259-270.
15. Chiang LC, Cheng HY, Liu MC, Chiang W, Lin CC: In vitro anti-herpes simplex viruses and anti-adenoviruses activity of twelve traditional used medicinal plants in Taiwan. Biol Pharm Bull 2003;26:1600-1604. (Pubitemid 41699643)
16. Lin HY: Studies on the chemical constituents and antihyperglycemic effect of Boussingaultia gracilis [Master's thesis]. China Medical College, Taichung, Taiwan, 1986.
17. Wang L, Bang CY, Choung SY: Anti-obesity and hypolipidemic effects of Boussingaultia gracilis Miers var. pseudobaselloides Bailey in obese rats. J Med Food 2011;14:17-25.
18. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957;226:497-509.
19. Shimizu S, Yasui K, Tani Y, Yamada H: Acyl-CoA oxidase from Candida tropicalis. Biochem Biophys Res Commun 1979;91: 108-113. (Pubitemid 10183348)
20. Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F: SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004;86:839-848. (Pubitemid 39602764)
21. Wilentz RE, Witters LA, Pizer ES: Lipogenic enzymes fatty acid synthase and acetyl-coenzyme A carboxylase are co expressed with sterol regulatory element binding protein and Ki-67 in fetal tissues. Pediatr Dev Pathol 2000;3:525-531.
22. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado de Oliveira R, Leid M, McBurney MW, Guarente L: Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-c. Nature 2004;429:771-776. (Pubitemid 38833129)
23. Ruderman N, Prentki M: AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 2004;3:340-351. (Pubitemid 38499761)
24. Chiu NY, Chang KH: The Illustrated Medicinal Plants of Taiwan, Vol. 3 (Mandarin Chinese edition). SMG Publishing Inc., Taipei, 1995.
25. Lin HY, Kuo SC, Chao PD, Lin TD: A new sapogenin from Boussingaultia gracilis. J Nat Prod 1988;51:797-798.
26. Rosen ED, Spiegelman BM: Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 2000;16:145-171. (Pubitemid 32037503)
27. Kolehmainen M, Vidal H, Alhava E, Uusitupa MI: Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res 2001;9:706-712. (Pubitemid 33603885)
28. Hardie DG, Carling D: The AMP-activated protein kinase - fuel gauge of the mammalian cell Eur J Biochem 1997;246: 259-273. (Pubitemid 27232500)
29. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, Zang M: AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 2011;13:376-388.